Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The ...

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Rigel Pharmaceuticals, Inc. before investing. In this article, we go over a few ...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.

Virginia State Police on Wednesday released more information about the man who died after jumping off the Route 288 bridge into the James River.